DKA was observed by Henry et al. 20, Sands et al. 21 and Cherney et al. 23, 24, 25, 28 when SGLT-2 inhibitors were added to insulin for treatment of T1DM. The gene discussed is SLC5A2; the disease is type 1 diabetes mellitus.